Comparing duration of response and duration of clinical benefit between fulvestrant treatment groups in the CONFIRM trial: Application of new methodology

  1. Garnett, S.A.
  2. Martin, M.
  3. Jerusalem, G.
  4. Petruzelka, L.
  5. Torres, R.
  6. Bondarenko, I.N.
  7. Khasanov, R.
  8. Verhoeven, D.
  9. Pedrini, J.L.
  10. Smirnova, I.
  11. Lichinitser, M.R.
  12. Pendergrass, K.
  13. Lindemann, J.P.O.
  14. Di Leo, A.
Revista:
Breast Cancer Research and Treatment

ISSN: 1573-7217,  0167-6806

Ano de publicación: 2013

Volume: 138

Número: 1

Páxinas: 149-155

Tipo: Artigo

DOI: 10.1007/S10549-012-2395-8 GOOGLE SCHOLAR lock_openAcceso aberto editor
Fonte de datos: Scopus